BioTelemetry (BEAT) Tops Q2 EPS by 2c; Raises Outlook
Get Alerts BEAT Hot Sheet
Join SI Premium – FREE
BioTelemetry (NASDAQ: BEAT) reported Q2 EPS of $0.23, $0.02 better than the analyst estimate of $0.21. Revenue for the quarter came in at $58.1 million versus the consensus estimate of $58.39 million.
Increases full year 2017 revenue guidance to $285 million to $290 million, with expected adjusted EBITDA of approximately 23% of revenue.
For earnings history and earnings-related data on BioTelemetry (BEAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Planet Labs (PL) Reports In-Line Q4 EPS, provides guidance
- Sprinklr (CXM) Tops Q4 EPS by 4c; offers guidance
- Oxford Industries (OXM) Reports In-Line Q4 EPS, provides guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!